Ibrutinib-MPEA (Compound 20) is ibrutinib derivative. Ibrutinib is a covalent and irreversible inhibitor of Brutons tyrosine kinase (BTK) that has been used to treat haematological malignancies[1].
Molecular Weight:
581.71
Purity:
99.71
CAS Number:
[1710768-30-1]
Formula:
C32H39N9O2
Target:
Btk
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
